Sumitomo Mitsui Trust Holdings, Inc. Ab Cellera Biologics Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

  • $142 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023
BUY
$4.6 - $7.95 $73,002 - $126,166
15,870 Added 33.85%
62,759 $288,000
Q4 2022

Jan 30, 2023
BUY
$9.48 - $14.52 $38,422 - $58,849
4,053 Added 9.46%
46,889 $474,000
Q3 2022

Oct 21, 2022
BUY
$9.2 - $13.68 $394,091 - $585,996
42,836 New
42,836 $424,000

Others Institutions Holding ABCL

# of Institutions
153
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $787M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email